Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Involvement of nurses in physician-assisted dying.
Bilsen JJ, Vander Stichele RH, Mortier F, Deliens L. Bilsen JJ, et al. J Adv Nurs. 2004 Sep;47(6):583-91. doi: 10.1111/j.1365-2648.2004.02982.x. J Adv Nurs. 2004. PMID: 15324424
End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey.
Deliens L, Mortier F, Bilsen J, Cosyns M, Vander Stichele R, Vanoverloop J, Ingels K. Deliens L, et al. Lancet. 2000 Nov 25;356(9244):1806-11. doi: 10.1016/s0140-6736(00)03233-5. Lancet. 2000. PMID: 11117913
[Euthanasia and other medical decisions concerning the end of life in Belgium: epidemiologic studies].
Deliens L, Mortier F, Bilsen J, Cosyns M, Vander Stichele R, Vanoverloop J, Ingels K, Bernheim J. Deliens L, et al. Rev Med Liege. 2001 Jun;56(6):443-52. Rev Med Liege. 2001. PMID: 11496725 French.
Attitudes, sociodemographic characteristics, and actual end-of-life decisions of physicians in Flanders, Belgium.
Mortier F, Bilsen J, Vander Stichele RH, Bernheim J, Deliens L. Mortier F, et al. Med Decis Making. 2003 Nov-Dec;23(6):502-10. doi: 10.1177/0272989X03260137. Med Decis Making. 2003. PMID: 14672110
Drugs used for euthanasia in Flanders, Belgium.
Vander Stichele RH, Bilsen JJ, Bernheim JL, Mortier F, Deliens L. Vander Stichele RH, et al. Among authors: bilsen jj. Pharmacoepidemiol Drug Saf. 2004 Feb;13(2):89-95. doi: 10.1002/pds.863. Pharmacoepidemiol Drug Saf. 2004. PMID: 14998070
The incidence and characteristics of end-of-life decisions by GPs in Belgium.
Bilsen J, Stichele RV, Mortier F, Bernheim J, Deliens L. Bilsen J, et al. Fam Pract. 2004 Jun;21(3):282-9. doi: 10.1093/fampra/cmh312. Fam Pract. 2004. PMID: 15128690
Physician-assisted death: attitudes and practices of community pharmacists in East Flanders, Belgium.
Bilsen J, Bauwens M, Bernheim J, Stichele RV, Deliens L. Bilsen J, et al. Palliat Med. 2005 Mar;19(2):151-7. doi: 10.1191/0269216305pm993oa. Palliat Med. 2005. PMID: 15810755
Medical end-of-life decisions in neonates and infants in Flanders.
Provoost V, Cools F, Mortier F, Bilsen J, Ramet J, Vandenplas Y, Deliens L; Neonatal Intensive Care Consortium. Provoost V, et al. Lancet. 2005 Apr 9-15;365(9467):1315-20. doi: 10.1016/S0140-6736(05)61028-8. Lancet. 2005. PMID: 15823381
The use of drugs with a life-shortening effect in end-of-life care in neonates and infants.
Provoost V, Cools F, Bilsen J, Ramet J, Deconinck P, Vander Stichele R, Vande Velde A, Van Herreweghe I, Mortier F, Vandenplas Y, Deliens L. Provoost V, et al. Intensive Care Med. 2006 Jan;32(1):133-9. doi: 10.1007/s00134-005-2863-2. Epub 2005 Nov 15. Intensive Care Med. 2006. PMID: 16292521
Dying at home or in an institution using death certificates to explore the factors associated with place of death.
Cohen J, Bilsen J, Hooft P, Deboosere P, van der Wal G, Deliens L. Cohen J, et al. Health Policy. 2006 Oct;78(2-3):319-29. doi: 10.1016/j.healthpol.2005.11.003. Epub 2005 Dec 15. Health Policy. 2006. PMID: 16343687
Feedback